XENE

Xenon Pharmaceuticals Inc. - Common Shares (XENE)

About Xenon Pharmaceuticals Inc. - Common Shares (XENE)

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Details

Daily high

$40.26

Daily low

$38.60

Price at open

$40.00

52 Week High

$72.66

52 Week Low

$35.97

Market cap

3.8B

Dividend yield

Volume

4.0M

Avg. volume

1.6M

P/E ratio

-8.38

Xenon Pharmaceuticals Inc. - Common Shares News